Patent · US Expired

Method for enhancing the anti-tumor therapeutic index of interleukin-2

US5830452A · kind A · utility

27Cited by
26References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 1994
Grant dateNov 3, 1998
Priority date
Expiry dateJul 11, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/2013
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to a method for enhancing the therapeutic index of a compound that is useful to treat tumors. More specifically, the present invention relates to a method for administering IL-2 to a tumor patient to maximize the therapeutic efficacy and minimize the toxicity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.